{"id":"W1567909777","doi":"10.1111/j.1464-410x.2010.09359.x","title":"Efficacy and safety of tolterodine extended‐release in men with overactive bladder symptoms treated with an α‐blocker: effect of baseline prostate‐specific antigen concentration","year":2010,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Tolterodine; Medicine; Overactive bladder; Urology; Tolerability; Placebo; International Prostate Symptom Score; Urinary retention; Urinary incontinence; Urination; Prostate; Internal medicine; Urinary system; Adverse effect; Lower urinary tract symptoms","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001159862,0.0003986109,0.001511903,0.0002360154,0.0001572441,0.0004178868,0.000293005,0.0006011265,0.001539126],"category_scores_gemma":[0.002122,0.0002581693,0.00101505,0.0001903297,0.0003088144,0.0004031077,0.0001877122,0.0007430625,0.0001859022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002015759,"about_ca_system_score_gemma":0.0002108165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002370221,"about_ca_topic_score_gemma":0.0006398625,"domain_scores_codex":[0.9994783,0.0002694618,0.00006019877,0.00007363661,0.0000736482,0.00004488019],"domain_scores_gemma":[0.9985972,0.0006185393,0.0004114558,0.00007371834,0.00004939676,0.0002496651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8412062,0.006272276,0.03970233,0.001077908,0.004006382,0.0001688514,0.000157763,0.0007778749,0.02381629,0.00003681685,0.0003059163,0.08247147],"study_design_scores_gemma":[0.1720812,0.4678071,0.3459353,0.0001721681,0.004959448,0.000677012,0.0001589592,0.001790301,0.004653865,0.0001006423,0.001608426,0.00005559511],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927045,0.006393008,0.0001279987,0.00008775954,0.00004038893,0.0000741841,0.0001349057,0.00001400352,0.0004232617],"genre_scores_gemma":[0.9981266,0.001049603,0.00018757,0.0001068766,0.0001164724,0.0000434975,0.0001236749,0.000003077945,0.000242636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001539126,"threshold_uncertainty_score":0.006134033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006142297538415865,"score_gpt":0.2650052168537247,"score_spread":0.2588629193153089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}